Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential risk of inflammation of the colon (colitis) (English, HTML)

Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential risk of inflammation of the colon (colitis): English HTML file. From Health Canada, updated May 2024. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2024-05-08

Health Canada reviewed the potential risk of colitis with Aubagio use after finding reports (since being marketed) of colitis as part of routine review of information received from the manufacturer. Also, the product safety information of a closely-related drug, Arava (leflunomide) was updated to include a new warning for colitis. In Canada, the product safety information for Aubagio does not mention the risk of colitis.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data